Publications by authors named "Thebuoshon Amalathasan"

Currently, oral anticoagulants are considered the gold standard for stroke prevention in patients with atrial fibrillation. Despite the efficacy of oral anticoagulants in reducing stroke incidence, patients are at risk of developing adverse reactions such as excessive bleeding and bruising, and can also have drug-drug interactions. In the early 2000s, a minimally invasive technique called the left atrial appendage closure emerged as an alternative for stroke prevention in atrial fibrillation patients who could not tolerate oral anticoagulants.

View Article and Find Full Text PDF

Colorectal adenocarcinoma is the neoplastic proliferation of glandular tissue in the distal gastrointestinal system and can be managed using surgical resection, novel chemotherapeutic regimens, and radiation therapy. Epstein-Barr virus (EBV) is a common double-stranded DNA virus that has the potential to transform B-cells into lymphoproliferative disorders given the presence of particular conditions such as immunocompromised and chronic inflammatory states. Colorectal cancer is one of the most common malignancies worldwide; however, the additional finding of EBV-positive lymphoma in a patient with a history of colorectal malignancy is uncommon, and this phenomenon has not been thoroughly explored.

View Article and Find Full Text PDF

Synopsis of recent research by authors named "Thebuoshon Amalathasan"

  • - Thebuoshon Amalathasan's research focuses on innovative approaches to medical concerns in patients with specific conditions, particularly in the context of stroke prevention and cancer-related complications.
  • - His recent article discusses the potential of Left Atrial Appendage Closure (LAAC) as a primary stroke prevention method for patients with atrial fibrillation who cannot tolerate anticoagulants, highlighting its minimally invasive nature and alternative to traditional treatments.
  • - Additionally, Amalathasan has explored the rare occurrence of Epstein-Barr Virus (EBV) lymphoma in a patient with a history of colorectal adenocarcinoma, emphasizing the need for further research into the association between viral infections and malignancies in immunocompromised patients.